Molecular mechanisms of methoctramine binding and selectivity at muscarinic acetylcholine receptors

Molecular Pharmacology

Volumn 86, Issue 2, 2014, Pages 180-192

  Jakubík, Jan ^a   Zimčík, Pavel ^a   Randáková, Alena ^a   Fuksová, Květoslava ^b   El Fakahany, Esam E ^c   Doležal, Vladimír ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL BOTANY   (Czech Republic)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; GREEN FLUORESCENT PROTEIN; LYSINE; METHOCTRAMINE; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; RECEPTOR SUBTYPE;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; DISSOCIATION; ENERGY TRANSFER; FLUORESCENCE; HYDROGEN BOND; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

BINDING SITES; BINDING, COMPETITIVE; CELL LINE, TUMOR; COUMARINS; DIAMINES; DNA TOPOISOMERASES, TYPE I; DNA, MITOCHONDRIAL; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; ISOQUINOLINES; MITOCHONDRIA; RECEPTORS, MUSCARINIC;

EID: 84903585210     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.093310     Document Type: Article

References (32)

1. Antony J, Kellershohn K, Mohr-Andrä M, Kebig A, Prilla S, Muth M, Heller E, Disingrini T, Dallanoce C, and Bertoni S et al. (2009) Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity. FASEB J 23:442-450.
2. Bonner TI (1989) The molecular basis of muscarinic receptor diversity. Trends Neurosci 12:148-151.
3. Bonner TI, Buckley NJ, Young AC, and Brann MR (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237:527-532. (Pubitemid 17125922)
4. Boselli C and Grana E (1995) Mode of antagonism of methoctramine, AF-DX 116 and hexahydrosiladifenidol in guinea-pig left atrium and ileum: comparison of Schild and resultant analysis. J Auton Pharmacol 15:115-127.
5. Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD et al.(2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of the ACM/IEEE conference on supercomputing (SC06), Article No. 84, ACM Press, New York.
6. Caulfield MP (1993) Muscarinic receptors - characterization, coupling and function. Pharmacol Ther 58:319-379.
7. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
8. Christopoulos (1998) Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log. Trends Pharmacol Sci 19:351-357.
9. Daval SB, Valant C, Bonnet D, Kellenberger E, Hibert M, Galzi JL, and Ilien B (2012) Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors. J Med Chem 55:2125-2143.
10. Giraldo E, Micheletti R, Montagna E, Giachetti A, Viganò MA, Ladinsky H, and Melchiorre C (1988) Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. J Pharmacol Exp Ther 244: 1016-1020. (Pubitemid 18090122)
11. Gnagey AL, Seidenberg M, and Ellis J (1999) Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors. Mol Pharmacol 56:1245-1253.
12. 2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482:547-551.
13. Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, Singhal M, Xu L, Mendes P, and Kummer U (2006) COPASI - a COmplex PAthway SImulator. Bioinformatics 22:3067-3074. (Pubitemid 44884083)
14. Ilien B, Franchet C, Bernard P, Morisset S, Weill CO, Bourguignon JJ, Hibert M, and Galzi JL (2003) Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties. J Neurochem 85:768-778. (Pubitemid 36531940)
15. 4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists. FEBS Lett 377:275-279.
16. Jakubík J, El-Fakahany EE, and Tuček S (2000) Evidence for a tandem two-site model of ligand binding to muscarinic acetylcholine receptors. J Biol Chem 275:18836-18844.
17. Jakubík J, Krejcí A, and Doležal V (2005) Asparagine, valine, and threonine in the third extracellular loop of muscarinic receptor have essential roles in the positive cooperativity of strychnine-like allosteric modulators. J Pharmacol Exp Ther 313:688-696.
18. Jakubík J and Tuček S (1994) Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation. Br J Pharmacol 113:1529-1537.
19. Järv J, Hedlund B, and Bartfai T (1979) Isomerization of the muscarinic receptor. antagonist complex. J Biol Chem 254:5595-5598. (Pubitemid 9245788)
20. 3) receptors. Mol Pharmacol 60:761-767.
21. 3 muscarinic acetylcholine receptor. Nature 482:552-556.
22. Lazareno S and Birdsall NJ (1995) Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G proteincoupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48:362-378.
23. Lee NH, Fryer AD, Forray C, and el-Fakahany EE (1989) Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses. J Pharmacol Exp Ther 251:992-999. (Pubitemid 20024915)
24. Leppik RA, Miller RC, Eck M, and Paquet JL (1994) Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor. Mol Pharmacol 45:983-990. (Pubitemid 24155790)
25. Matsui H, Lazareno S, and Birdsall NJ (1995) Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. Mol Pharmacol 47: 88-98.
26. Melchiorre C, Cassinelli A, and Quaglia W (1987) Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptors. J Med Chem 30:201-204. (Pubitemid 17221640)
27. Melchiorre C, Minarini A, Angeli P, Giardinà D, Gulini U, and Quaglia W (1989) Polymethylene tetraamines as muscarinic receptor probes. Trends Pharmacol Sci (Suppl):55-59. (Pubitemid 20004464)
28. Mohr M, Heller E, Ataie A, Mohr K, and Holzgrabe U (2004) Development of a new type of allosteric modulator of muscarinic receptors: hybrids of the antagonist AF-DX 384 and the hexamethonio derivative W84. J Med Chem 47:3324-3327. (Pubitemid 38702725)
29. Proška J and Tuček S (1994) Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Mol Pharmacol 45: 709-717.
30. Tuček S and Proška J (1995) Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol Sci 16:205-212.
31. Waelbroeck M (1994) Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol Pharmacol 46:685-692.
32. Wess J (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10:69-99.